Praluent's New Indication; ORBITA-2; Medicare $$ Changes - MedPage Today

Praluent's New Indication; ORBITA-2; Medicare $$ Changes  MedPage Today

Recent developments of interest in cardiovascular medicine.



Comments

Popular posts from this blog

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease - Vascular Disease Management